Whether they gave the peptide body-wide or delivered it directly to the kidneys, it reduced the movement of immune cells into the kidneys, resolved inflammation and damage and improved kidney function, without increasing blood pressure, they report in the journal Kidney International
A study protocol, cosmetic product label, or registered trial design describes research conditions, while personal medical decisions require clinician review of risks, diagnosis, alternatives, and regulatory status [7], [8]
Patients should review the full prescribing information and discuss risks with their provider
Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment
Acculturation and Cardiometabolic Abnormalities Among Chinese and Korean Americans